1. |
Lyman GH, Khorana AA. Cancer,clots and consensus: new understanding of an old problem. J Clin Oncol, 2009, 27(29): 4821-4826.
|
2. |
Struve S, Wendtner CM. Prevention and treatment of venous thromboembolism in patients with cancer. Dtsch Med Wochenschr, 2012, 137(40): 2007-2009.
|
3. |
Kröger K, Moerchel C. Deep vein thrombosis: how to care for risk patients. MMW Fortschr Med, 2010, 152(44): 35-39.
|
4. |
Shtherland DE , Wei tz IC, Liebman HA. Thromboembolic compli cations of cancer:epidemiology, pathogenesis, diagnosis,and treatment. Am J Hemato, 2003, 72(1): 43-52.
|
5. |
Sierra-Montenegro E, Sierra-Luzuriaga G, Calle-Loffredo D, et al. Rectal cancer and trousseau syndrome. case report. Cir Cir, 2013, 81(3): 242-245.
|
6. |
Bobek V. Anticoagulant and fibrinolytic drugs - possible agents in treatment of lung cancer. Anticancer Agents Med Chem, 2012, 12(6): 580-588.
|
7. |
Monreal M,Lensing AM,Prins MH, et al. Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. Thromb Haemost, 2004, 2(6): 876.
|
8. |
Kleinjan A, van Doormaal FF, Prins MH, et al. Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism. Neth J Med, 2012, 70(7): 311-317.
|
9. |
de Oliveira AL, Ribeiro A, Reis LF, et al. Chest radiography as a method of screening for occult cancer in patients with idiopathic deep vein thrombosis. Angiology, 2012, 63(5): 378-379.
|
10. |
Semb VB, Tveit A. Limited malignancy screening of patients with idiopathic venous thromboembolism. Tidsskr Nor Laegeforen, 2014, 134(4): 407-411.
|
11. |
Yu JL, May L, Lhotak V, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood, 2005, 105(4): 1734-1741.
|
12. |
van den Berg YW, Osanto S, Reitsma PH, et al. The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood, 2012, 119(4): 924-932.
|
13. |
Wang JG, Geddings JE, Aleman MM, et al. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood, 2012, 119(23): 5543-5552.
|
14. |
Anand M, Brat DJ. Oncogenic regulation of tissue factor and thrombosis in cancer. Thromb Res, 2012, 129(Suppl 1): S46-S49.
|
15. |
喻晓洁, 胡小青, 罗兵. 化疗对卵巢癌血浆纤维蛋白原和D-二聚体水平的影响. 实用癌症杂志, 2009, 24(1): 87.
|
16. |
Tiedje V, Dunkler D, Ay C, et al. The role of fibrinogen plasma levels, the-455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis. Thromb Haemost, 2011, 8: 106.
|
17. |
Simanek R, Vormittag R, Ay C, et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost, 2010, 8(1): 114-120.
|
18. |
Mackman N, Tilley RE, Key NS, et al. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol, 2007, 27: 1687.
|
19. |
Wolberg AS, Mast AE. Tissue factor and factor VIIa--hemostasis and beyond. Thromb Res, 2012, 129(Suppl 2): S1-4.
|
20. |
Owens AP, Mackman N. Role of tissue factor in atherothrombosis. Curr Atheroscler Rep, 2012, 14(5): 394-401.
|